Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Giphy

The next few days will tell us whether Republican leaders prepared adequately for the disastrous Congressional Budget Office estimates of the House Obamacare replacement bill. It's one thing to say, "we're not going to compete with a law that forces everyone to buy coverage." It's another thing to fight headlines about 24 million Americans losing coverage.

Quick recap:

  • Coverage losses: 14 million people in 2018, 24 million over 10 years
  • Savings: $337 billion over 10 years
  • Medicaid cuts: $880 billion over 10 years
  • Premiums: 15 to 20 percent higher in 2018-19, 10 percent lower in 10 years

Top Republican responses:

  • House Speaker Paul Ryan told reporters he was "encouraged" by the report — because of the savings and long-term lower premiums — and it "exceeded my expectations."
  • Health and Human Services secretary Tom Price said CBO didn't look at everything Republicans are planning: "It didn't look at the regulatory reforms that we're going to put into place. It didn't look at the state innovation grants. It didn't look at the flexibility that we're going to allow the states."
  • Office of Management and Budget director Mick Mulvaney, on Medicaid coverage losses: "The CBO is saying it happens on day one, which is just absurd."

But here are the Republicans to watch:

  • Top conservative critics of the bill — including House Freedom Caucus chairman Mark Meadows, Freedom Caucus member Jim Jordan, and Sens. Rand Paul and Ted Cruz — were laying low.
  • But Caitlin Owens reports that Sen. Mike Lee — another conservative critic — said his concerns about the bill "have not been eliminated by the CBO report."
  • Sen. Susan Collins, one of the GOP moderates who's skeptical about the bill: "The topline numbers are alarming on the loss of coverage."
  • Sen. Lindsey Graham: "Let's say the CBO is half right—that should be cause for concern," per the Wall Street Journal.
  • (As one Senate Democratic aide noted: "We heard three different messages from the House, Senate, and White House. Clearly zero attempt at message coordination.")

The bottom line: It's summed up in this tweet from former Senate Republican aide Rodney Whitlock: "Critical, soul searching moment for GOP. Ignore #CBOscore and plow ahead or admit that some ideas might just be problematic.

FWIW: Politico reports that the White House's internal projections were even worse: 26 million would lose coverage over the next 10 years.

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities tied to Iranian-backed militia groups in Syria was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

4 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios